Medical Device Standards Order (Standards for Natural Latex Rubber Condoms) 2008

Administered by Department of Health, Disability and Ageing

Legislation au F2008L04335 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

Subject:  MEDICAL DEVICE STANDARDS ORDER (STANDARDS FOR NATURAL LATEX RUBBER CONDOMS) 2008 

 

Section 41CB, Therapeutic Goods Act 1989

 

OUTLINE

 

Medical Device Standards Order (Standards for Natural Latex Rubber Condoms) 2008 (MDSO (Rubber Condoms) 2008) is an Order made by the delegate of the Minister for Health and Ageing under section 41CB of the Therapeutic Goods Act 1989 (the Act).  Section 41CB of the Act authorises the Minister, or her delegate, by written Order, to determine appropriate medical standards that are applicable to kinds of medical devices and to determine that medical devices that comply with those standards are to be treated as complying with those parts of the essential principles specified in the standards.

 

MDSO (Rubber Condoms) 2008 introduces standards that are relevant to natural latex rubber condoms to demonstrate compliance with essential principles.  The standards set out in MDSO (Rubber Condoms) 2008 are the following:

  • ISO 4074: 2002 Natural latex rubber condoms – Requirements and test methods,

-            including Technical Corrigendum 1: 2003, but not

-            Technical Corrigendum 2: 2008.

 

Electronic or hard copies of this standard can be purchased on-line from SAI Global Limited at the following website: http://www.saiglobal.com.

 

MDSO (Rubber Condoms) 2008 was signed by the delegate of the Minister on 14 November 2008 and commenced on the day after it was registered on the Federal Register of Legislative Instruments.

 

BACKGROUND

 

The Act provides for the establishment and maintenance of a national system of controls relating to the quality, safety and efficacy of therapeutic goods that are used in Australia (whether manufactured in Australia or elsewhere) or exported from Australia.

 

Section 41CB of the Act authorises the Minister, or the Minister’s delegate, by written instrument called an Order, to determine medical device standards for kinds of medical devices set out in the Order and to determine that medical devices of those kinds that comply with the standard are to be treated as complying with those parts of the essential principles specified in the standard. 

 

The essential principles set out the requirements relating to the safety and performance characteristics of medical devices that must be complied with before a device can be imported, supplied or exported.  Compliance with applicable medical device standards is not required, but it is one way to establish compliance with the essential principles. If a manufacturer chooses to apply a medical device standard set out in the Order, and this is applied correctly to a device, the device is presumed to comply with the parts of the essential principles set out in the Order (section 41BH of the Act).

 

MDSO (Rubber Condom) 2008 determines medical device standards for manufacturers of natural latex rubber condoms to use in order to demonstrate compliance with Essential Principles 2, 3, 4, 5, 6, 7 (except 7.4), 8.4 and 9.2.

 

CHANGES TO STANDARDS

 

International ‘ISO’ and ‘EN’ device standards are living documents that are developed and constantly being updated by groups of international experts.  Australian representatives are involved in some of these committees.  There is extensive consultation on the ISO and EN standards during their development and subsequent review.  With both industry and the TGA seeking to optimise Australia’s position in the global device market, it is imperative that Australia’s standards do not fall out of step with the international market.

 

Updates to international device standards reflect changes to international best practice as well as the emergence of new technologies and new manufacturing procedures.  Where relevant the latest international standards are adopted by leading regulators including Australia, Europe, the USA and Canada.

 

Australia will very quickly fall behind if it fails to adopt the latest international standards.  In the longer term not keeping up with changes to the relevant international standards will lead to a unique regulatory system in Australia, making regulatory compliance more difficult and costly for importers and/or exporters of medical devices into Australia.  The updated standards referenced in MDSO (Rubber Condoms) 2008 reflect the current relevant international standards for natural latex rubber condoms.

 

CONSULTATION

 

Key industry stakeholders including the Medical Industry Association of Australia (now the Medical Technology Association of Australia), the Australian Dental Industry Association and AusBiotech were consulted on the adoption of MDSO (Rubber Condoms) 2008 for natural latex rubber condoms during July-August 2008.  Industry groups supported the adoption of these standards. 

 

REGULATION IMPACT STATEMENT

 

Compliance with the proposed medical device standards is voluntary and members of industry may choose alternative means to demonstrate compliance with the Essential Principles.  All stakeholders, including industry and Standards Australia have been consulted during the development of the proposed new regulatory system for medical devices.  There was overall support for the adoption of international standards.  The Office of Regulation Review assessed the proposal for voluntary standards and, as it is not prohibitive either in terms of costs or time delays, the proposal is considered to be non-regulatory and as such a Regulatory Impact Statement is not required.

 

APPLICATION OF THE LEGISLATIVE INSTRUMENTS ACT 2003 (THE LIA)

 

Under paragraph 6(d)(i) of the LIA, an instrument is a legislative instrument for the purposes of the LIA if it is declared to be a disallowable instrument under legislation in force before the commencement of the LIA.  This determination is a legislative instrument and it is subject to tabling and disallowance in the Parliament under sections 38 and 42 of the LIA, respectively.

 

 

Overview

The Medical Device Standards Order (Standards for Natural Latex Rubber Condoms) 2008 (MDSO (Rubber Condoms) 2008) was enacted to address the need for updated medical device standards in Australia, specifically for natural latex rubber condoms. This Order was made by the delegate of the Minister for Health and Ageing under section 41CB of the Therapeutic Goods Act 1989, with the objective of ensuring that medical devices meet the essential principles for quality, safety, and efficacy. The Act provides a framework for regulating therapeutic goods in Australia, and the MDSO (Rubber Condoms) 2008 introduces standards relevant to natural latex rubber condoms to demonstrate compliance with these essential principles. By aligning with international standards, the Order aims to maintain Australia's competitiveness in the global medical device market while ensuring consumer safety.

Scope and Application

The Medical Device Standards Order (Standards for Natural Latex Rubber Condoms) 2008 (MDSO (Rubber Condoms) 2008) applies to manufacturers of natural latex rubber condoms, ensuring they adhere to specified medical standards to demonstrate compliance with certain essential principles outlined under the Therapeutic Goods Act 1989. This Order is instrumental in maintaining the quality, safety, and efficacy of therapeutic goods used or exported from Australia, thereby ensuring that natural latex rubber condoms meet the necessary safety and performance criteria before they can be imported, supplied, or exported. The standards set out in MDSO (Rubber Condoms) 2008 are based on ISO 4074: 2002, including its Technical Corrigendum 1: 2003, which helps keep Australian regulations in line with international best practices. Compliance with these standards is voluntary, allowing manufacturers to choose alternative means of demonstrating compliance with the essential principles. This legislative instrument is subject to tabling and disallowance in the Parliament under the Legislative Instruments Act 2003.

Key Provisions

The Medical Device Standards Order (Standards for Natural Latex Rubber Condoms) 2008 (MDSO (Rubber Condoms) 2008) sets out the standards that manufacturers must use to demonstrate compliance with essential principles for natural latex rubber condoms (section 41CB). The standards are based on the ISO 4074: 2002 standard for natural latex rubber condoms, including Technical Corrigendum 1: 2003 but excluding Technical Corrigendum 2: 2008. These standards are intended to ensure the safety and performance of condoms, and compliance is voluntary, though it provides a presumption of compliance with the essential principles (section 41BH). Manufacturers who wish to demonstrate compliance with the essential principles may do so by complying with these standards, but they may also use alternative methods. The Act imposes obligations on manufacturers to ensure that natural latex rubber condoms meet the essential principles for safety and performance. By complying with the standards set out in the MDSO (Rubber Condoms) 2008, manufacturers can demonstrate that their products meet these essential principles. However, it is not mandatory for manufacturers to comply with the standards; they may choose to demonstrate compliance in other ways, provided they can show that their products meet the essential principles. The essential principles cover a range of requirements, including the design, manufacture, labelling, and performance of medical devices, and are intended to ensure that devices are safe and effective for their intended use. There are no specific offences, penalties, or consequences for non-compliance with the MDSO (Rubber Condoms) 2008, as compliance with the standards is voluntary. However, if a manufacturer chooses to comply with the standards and subsequently markets a product that does not meet the essential principles, they may be subject to regulatory action under the Therapeutic Goods Act 1989. The consequences of non-compliance with the essential principles can include product recalls, fines, and legal action. The maximum penalties for offences under the Therapeutic Goods Act 1989 vary depending on the offence, but can include fines of up to $1.65 million for corporations and $330,000 for individuals, as well as imprisonment for up to five years. It is important for manufacturers to ensure that their products meet the essential principles, regardless of whether they choose to comply with the standards set out in the MDSO (Rubber Condoms) 2008.

Legal classification tags

Area of Law
Medical Law
Instrument
Order
Concepts
Definitions & Interpretation
Regulatory Standards
Licensing & Registration

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.